Boxed Warning Added to Asthma, Allergy Med; EUA for Remdesivir

Inbox

x

MPR Daily Dose <editor@email.empr.com> Unsubscribe

2:56 AM (10 hours ago)

to me

If you are having trouble viewing this email, click here.

MUST READS Boxed Warning Added to Montelukast Labeling Regarding Neuropsychiatric Events FDA Issues Emergency Use Authorization for Remdesivir Fensolvi Approved for Central Precocious Puberty SGLT2 Inhibitors Linked to Reduced Risk for Serious Renal Events Rituximab Biosimilar Truxima Now Available for Rheumatoid Arthritis COVID-19 Pipeline: Therapeutics and Vaccines CME/CE Spotlight Improved Outcomes for Naïve & Heavily Treatment—Experienced HIV Patients AMA PRA Category 1 Credit(s)TM, CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME